Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
ENTA holding history
Enanta Pharmaceuticals Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings
- Shares (Q2 2026)
- 81,005
- Value
- $1.18M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 81,005 | $1.18M | <0.1% | −35,956−30.7% | Reduced | Holders |
| Q1 2026 | 116,961 | $1.48M | <0.1% | +84,572+261.1% | Added | Holders |
| Q4 2025 | 32,389 | $510.8K | <0.1% | +20,469+171.7% | Added | Holders |
| Q3 2025 | 11,920 | $142.7K | <0.1% | −71,992−85.8% | Reduced | Holders |
| Q2 2025 | 83,912 | $634.4K | <0.1% | −3,955−4.5% | Reduced | Holders |
| Q1 2025 | 87,867 | $485.0K | <0.1% | −73,812−45.7% | Reduced | Holders |
| Q4 2024 | 161,679 | $929.7K | <0.1% | +40,660+33.6% | Added | Holders |
| Q3 2024 | 121,019 | $1.25M | <0.1% | +61,235+102.4% | Added | Holders |
| Q2 2024 | 59,784 | $775.4K | <0.1% | −42,841−41.7% | Reduced | Holders |
| Q1 2024 | 102,625 | $1.79M | <0.1% | −86,203−45.7% | Reduced | Holders |
| Q4 2023 | 188,828 | $1.78M | <0.1% | +75,156+66.1% | Added | Holders |
| Q3 2023 | 113,672 | $1.27M | <0.1% | +68,076+149.3% | Added | Holders |
| Q2 2023 | 45,596 | $975.8K | <0.1% | +29,942+191.3% | Added | Holders |
| Q1 2023 | 15,654 | $633.0K | <0.1% | −7,742−33.1% | Reduced | Holders |
| Q4 2022 | 23,396 | $1.09M | <0.1% | −11,303−32.6% | Reduced | Holders |
| Q3 2022 | 34,699 | $1.80M | <0.1% | +29,414+556.6% | Added | Holders |
| Q2 2022 | 5,285 | $250.0K | <0.1% | −4,018−43.2% | Reduced | Holders |
| Q1 2022 | 9,303 | $662.0K | <0.1% | +824+9.7% | Added | Holders |
| Q4 2021 | 8,479 | $634.0K | <0.1% | +8,479 | New | Holders |